We found that BCAT1 expression is decreased in substantia nigra of PD patients, and reduction of bcat-1 in C. elegans promotes neurodegeneration of cholinergic neurons and dopaminergic neurons expressing human α-synuclein. Here, BCAT1 is linked to Parkinson disease.